MEREDITH EVANS: Open Payments
NPI 1700347200 · GARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$664 in 34 payments from 12 companies in 2025. Trend: 2023 $800 · 2024 $609 · 2025 $664
Food & beverage: $564Education: $100
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $186 |
| PFIZER INC. | 9 | $167 |
| Abbott Laboratories | 4 | $71 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| ABBVIE INC. | 2 | $33 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Organon LLC | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: Veozah, NURTEC ODT, PREVNAR 20, FREESTYLE LIBRE 3, Auvelity, JARDIANCE, Kerendia, QULIPTA.
Industry payments across TX — which companies pay providers there.
